Search
for
Sort by
Research 211–240 of 1000+
- Gender differences in skin: A review of the literature
- Vitamin D and the skin: Focus on a complex relationship: A review
- Congenital Adrenal Hyperplasia
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Nonclassic Congenital Adrenal Hyperplasia
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Prescribing testosterone and DHEA: The role of androgens in women
- Testosterone in Women: Measurement and Therapeutic Use
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Symptom management in inflammatory bowel disease
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Plasmaproteinbindung endogener Glucocorticosteroide und deren Einfluss auf Haar- und Speichelkonzentrationen
- Histological and immunohistochemical examination of the effect of the nonsteroidal antiandrogen {flutamide} on some organs of the male reproductive system in albino rats
- Polycystic Ovary Syndrome and Cardiovascular Disease
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Emerging medication for the treatment of male hypogonadism
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Idiopathic Hirsutism*
- The Clinical Presentation of Systemic Lupus Erythematosus
- ANDROGENETIC ALOPECIA
- Post-finasteride syndrome: An emerging clinical problem
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract